|
[1] GEBLER A, ZABEL O, SELIGER B.The immunomodulatory capacity of mesenchymal stem cells[J].Trends Mol Med, 2012, 18 (2) :128-134.
|
|
[2]DEUSE T, STUBBENDORFF M, TANG-QUAN K, et al.Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells[J].Cell Transplant, 2010, 20 (5) :655-667.
|
|
[3]KITAZAWA Y, LI XK, XIE L, et al.Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats[J].Cell Transplant, 2011, 21 (2-3) :581-590.
|
|
[4]LUO C, JIA W, WANG K, et al.Human amniotic fluid stem cells suppress PBMC proliferation through IDO and IL-10-dependent pathways[J].Curr Stem Cell Res Ther, 2014, 9 (1) :36-45.
|
|
[5] TOBIN LM, HEALY ME, ENGLISH K, et al.Human mesenchymal stem cells suppress donor CD4 (+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease[J].Clin Exp Immunol, 2013, 172 (2) :333-348.
|
|
[6]SVOBODOVA E, KRULOVA M, ZAJICOVA A, et al.The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population[J].Stem Cells Dev, 2012, 21 (6) :901-910.
|
|
[7]MAKINO Y, YAMAZA H, AKIYAMA K, et al.Immune therapeutic potential of stem cells from human supernumerary teeth[J].J Dent Res, 2013, 92 (7) :609-615.
|
|
[8]ZHANG W, GE W, LI C, et al.Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells[J].Stem Cells Dev, 2004, 13 (3) :263-271.
|
|
[9] AGGARWAL S, PITTENGER MF.Human mesenchymal stem cells modulate allogeneic immune cell responses[J].Blood, 2005, 105 (4) :1815-1822.
|
|
[10] TACKE F, ZIMMERMANN HW.Macrophage heterogeneity in liver injury and fibrosis[J].J Hepatol, 2014, 60 (5) :1090-1096.
|
|
[11]FALLOWFIELD JA, MIZUNO M, KENDALL TJ, et al.Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis[J].J Immunol, 2007, 178 (8) :5288-5295.
|
|
[12]PELLICORO A, AUCOTT RL, RAMACHANDRAN P, et al.Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis[J].Hepatology, 2012, 55 (6) :1965-1975.
|
|
[13] IMAMURA M, OGAWA T, SASAGURI Y, et al.Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats[J].Gastroenterology, 2005, 128 (1) :138-146.
|
|
[14]THOMAS JA, POPE C, WOJTACHA D, et al.Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function[J].Hepatology, 2011, 53 (6) :2003-2015.
|
|
[15]BAECK C, WEHR A, KARLMARK KR, et al.Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury[J].Gut, 2012, 61 (3) :416-426.
|
|
[16] MLLER T, BEUTLER C, PICAH, et al.Increased T-helper 2cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier[J].Gastroenterology, 2013, 144 (5) :1116-1128.
|
|
[17]YANG ZL, CHENG K, SUN HG, et al.Changes in peripheral blood Th1 and Th2 cells in rat liver transplantation under different immune statuses[J].Genet Mol Res, 2013, 12 (4) :6939-6946.
|
|
[18]HUANG YH, YAN XS, PENG YQ, et al.Changes of Th1/Th2 cells in immunological liver injury[J].Chin Arch Tradit Chin Med, 2005, 23 (7) :1209-1210. (in Chinese) 黄育华, 晏雪生, 彭亚琴, 等.免疫性肝损伤小鼠Th1/Th2细胞的变化[J].中医药学刊, 2005, 23 (7) :1209-1210.
|
|
[19]BRENNDRFER ED, BRASS A, KARTHE J, et al.Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A Protease induces a Th1 to Th2 shift reversible by ribavirin therapy[J].J Immunol, 2014, 192 (4) :1671-1680.
|
|
[20] ZHU X, UETRECHT J.A novel T (H) 17-type cell is rapidly increased in the liver in response to acetaminophen-induced liver injury:T (H) 17 cells and the innate immune response[J].J Immunotoxicol, 2013, 10 (3) :287-291.
|
|
[21] HAMMERICH L, HEYMANN F, TACKE F.Role of IL-17 and Th17cells in liver diseases[J].Clin Dev Immunol, 2011, 2011:345803.
|
|
[22]PARK O, WANG H, WENG H, et al.In vivo consequences of liver-specific interleukin-22 expression in mice:Implications for human liver disease progression[J].Hepatology, 2011, 54 (1) :252-261.
|
|
[23]HOU L, JIE Z, DESAI M, et al.Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis[J].J Immunol, 2013, 190 (2) :621-629.
|
|
[24] KUMAR V.NKT-cell subsets:promoters and protectors in inflammatory liver disease[J].J Hepatol, 2013, 59 (3) :618-620.
|
|
[25]LU L, FENG M, GU J, et al.Restoration of intrahepatic regulatory T cells through MMP-9/13-dependent activation of TGF-beta is critical for immune homeostasis following acute liver injury[J].J Mol Cell Biol, 2013, 5 (6) :369-379.
|
|
[26]DIENES HP, DREBBER U.Pathology of immune-mediated liver injury[J].Dig Dis, 2010, 28 (1) :57-62.
|
|
[27] TUCKER RM, FELDMAN AG, FENNER EK, et al.Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia[J].J Hepatol, 2013, 59 (4) :790-796.
|
|
[28]am ESCH JS 2nd, KNOEFEL WT, KLEIN M, et al.Portal application of autologous CD133+bone marrow cells to the liver:a novel concept to support hepatic regeneration[J].Stem Cells, 2005, 23 (4) :463-470.
|
|
[29]von LTTICHAU I, NOTOHAMIPRODJO M, WECHSELBERGER A, et al.Human adult CD34-progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4[J].Stem Cells Dev, 2005, 14 (3) :329-336.
|
|
[30]LI Q, ZHOU X, SHI Y, et al.In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury[J].PLoS One, 2013, 8 (4) :e62363.
|
|
[31] WANG J, ZHOU X, CUI L, et al.The significance of CD14+monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis[J].Cytotherapy, 2010, 12 (8) :1022-1034.
|
|
[32]LIN H, XU R, ZHANG Z, et al.Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases[J].Cell Mol Immunol, 2011, 8 (1) :19-22.
|
|
[33] LEE MJ, JUNG J, NA KH, et al.Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl4-injured liver:potential application to the treatment of hepatic diseases[J].J Cell Biochem, 2010, 111 (6) :1453-1463.
|
|
[34] TANIMOTO H, TERAI S, TARO T, et al.Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow[J].Cell Tissue Res, 2013, 354 (3) :717-728.
|
|
[35] PAREKKADAN B, van POLL D, MEGEED Z, et al.Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells[J].Biochem Biophys Res Commun, 2007, 363 (2) :247-252.
|
|
[36] LIN N, HU K, CHEN S, et al.Nerve growth factor-mediated paracrine regulation of hepatic stellate cells by multipotent mesenchymal stromal cells[J].Life Sci, 2009, 85 (7-8) :291-295.
|
|
[37] DU Z, WEI C, CHENG K, et al.Mesenchymal stem cell-conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation[J].J Surg Res, 2013, 183 (2) :907-915.
|
|
[38] HIGASHIMOTO M, SAKAI Y, TAKAMURA M, et al.Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4+T-cell suppression[J].Eur J Immunol, 2013, 43 (11) :2956-2968.
|
|
[39]BUSCH SA, HAMILTON JA, HORN KP, et al.Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury[J].J Neurosci, 2011, 31 (3) :944-953.
|
|
[40]DAYAN V, YANNARELLI G, BILLIA F, et al.Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction[J].Basic Res Cardiol, 2011, 106 (6) :1299-1310.
|
|
[41] YLSTALO JH, BARTOSH TJ, COBLE K, et al.Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype[J].Stem Cells, 2012, 30 (10) :2283-2296.
|
|
[42]FURUHASHI K, TSUBOI N, SHIMIZU A, et al.Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages[J].J Am Soc Nephrol, 2013, 24 (4) :587-603.
|
|
[43]MATHIAS LJ, KHONG SM, SPYROGLOU L, et al.Alveolar macrophages are critical for the inhibition of allergic asthma by mesenchymal stromal cells[J].J Immunol, 2013, 191 (12) :5914-5924.
|
|
[44]ZHENG L, CHU J, SHI Y, et al.Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17[J].Cell Biosci, 2013, 3 (1) :46.
|
|
[45] EZQUER M, EZQUER F, RICCA M, et al.Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome[J].J Hepatol, 2011, 55 (5) :1112-1120.
|
|
[46]WANG L, LI J, LIU H, et al.A pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis[J].J Gastroenterol Hepatol, 2013, 28 (Suppl 1) :85-92.
|
|
[47]WANG D, ZHANG H, LIANG J, et al.Effect of allogeneic bone marrow-derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model[J].Clin Exp Med, 2011, 11 (1) :25-32.引证本文:CUI LN, HAN Y.Immunoregulatory effect of multipotent stem cells in liver injury and repair[J].J Clin Hepatol, 2014, 30 (9) :855-859. (in Chinese) 崔丽娜, 韩英.多能干细胞在肝脏损伤和修复过程中的免疫调节作用[J].临床肝胆病杂志, 2014, 30 (9) :855-859.
|
DownLoad: